19 results
8-K
EX-1.2
ADXS
Ayala Pharmaceuticals, Inc.
6 Jul 21
Advaxis and Biosight Announce Entry into Definitive Merger Agreement
6:03am
8-K
EX-1.1
ADXS
Ayala Pharmaceuticals, Inc.
6 Jul 21
Advaxis and Biosight Announce Entry into Definitive Merger Agreement
6:03am
8-K
EX-1.1
ADXS
Ayala Pharmaceuticals, Inc.
12 Apr 21
Advaxis, Inc. Announces $20 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:14pm
8-K
EX-1.1
ADXS
Ayala Pharmaceuticals, Inc.
27 Nov 20
Advaxis, Inc. Announces Closing of $9.2 Million Public Offering
4:34pm
8-K
EX-1.1
xxfrvdn9q0ki knq8k
8 May 20
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-1.1
p42z7tg721 6l
23 Jan 20
Advaxis, Inc. Announces Pricing of $10.5 Million Registered Direct Offering
4:05pm
8-K
EX-1.1
h6ml mj8guxgdkj
25 Jul 19
Advaxis, Inc. Announces Pricing of $16 Million Public Offering
5:19pm
8-K
EX-1.1
b3rxm 8q2xu4a63j5
5 Apr 19
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-1.1
iflgvqjd4360hx
11 Sep 18
Advaxis, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Warrants
12:00am
8-K
EX-1.1
yoy9d5 hwvbrvk
22 Feb 18
Advaxis Prices $20.0 Million Public Offering Of Common Stock
12:00am
8-K
EX-1.1
1bs5ow9943wk7wtkt
5 May 15
Other Events
12:00am
8-K
EX-1.1
vppk zxmsd77nbfex
19 Feb 15
Advaxis Completes $23 Million Financing
12:00am
8-K
EX-1.1
3cps78xp pq
22 Dec 14
Advaxis Completes $17 Million Financing
12:00am
8-K
EX-1.1
o5l5z7v
1 Apr 14
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next